Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.7413.438.0324.0616.71

What is the latest EV/Core EBITDA ratio of TTK HEALTHCARE ?

The latest EV/Core EBITDA ratio of TTK HEALTHCARE is 8.74 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20258.74
Mar202413.43
Mar20238.03
Mar202224.06
Mar202116.71

How is EV/Core EBITDA of TTK HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2025 8.74
-34.92
Mar2024 13.43
67.25
Mar2023 8.03
-66.63
Mar2022 24.06
43.99
Mar2021 16.71 -

Other Financial Ratios of TTK HEALTHCARE


Compare EV/Core EBITDA ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,494.9 Cr -0.8% -6.7% -28.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-0.8%

-6.7%

-28.1%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses